Research & Development: Page 93
-
PharmaVoice Team/PharmaVoice
The True Value of Educational Outcomes Measurement
VIEW on Medical Education August 2007 The True Value of Educational Outcomes Measurement Sherri Foster, Senior VP and General Manager Outcomes measurement has become the buzzword in continuing medical education (CME) over the past few years. It comes amid growing recognition among stak...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
Transforming U.S. Healthcare Quality Using CME
Transforming U.S. Healthcare Quality Using CME VIEW on Medical Education August 2007 cme2 Cathy Pagano, Executive Director John Marlow, Chief Medical Officer We believe the mission of all CME needs to be elevated to a whole new level to be clinically meaningful. Looking ahead, a new model...
By PharmaVoice Team • Jan. 2, 2008 -
Explore the Trendlineâž”
Getty Images
TrendlineArtificial intelligence & machine learning
After years of excited buzz around the potential of artificial intelligence and machine learning, pharma has begun to realize the true implications and potential value of these technologies.
By PharmaVoice staff -
PharmaVoice Team/PharmaVoice
Strengthening the Value of Live CME: Cutting-Edge Strategies to Engage Learners and Extend Reach
VIEW on Medical Education August 2007 Strengthening the Value of Live CME: Cutting-Edge Strategies to Engage Learners and Extend Reach Sarah Mooney, Director, Strategic Planning & Development Innovia Education Institute LLC In 2006, more than 2 million physicians and healthcare pr...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
Last Word
Throughout his career, Joseph Bolen, Ph.D., has been involved in unraveling the mysteries of drug discovery. Now in his positions as Senior VP of Research and Drug Discovery, a role in which he heads all biological research and related functions as well as all drug-discovery functions, and as Chi...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
Letter from the Editor
The pharmaceutical industry can no longer afford to be off-message — not even just once — in an exceedingly competitive marketplace. Silo busting continues to be a resounding theme in all areas of the industry, it’s a way to improve business processes, increase efficiencies, and stay on message. ...
By Taren Grom • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
A Born Leader -- Ethan Leder
By Kim Ribbink Ethan Leder has made a career out of establishing companies in niche markets. Now he is applying the skills he’s learned to evidence-based solutions specialist United BioSource Corp. With an entrepreneurial spirit and intense work ethic, Ethan D. Leder has made a career out of esta...
By Kim Ribbink • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
DIA 2007 -- Annual Conference
DIA Addresses extreme topics The 43rd Annual Meeting of the Drug Information Association DIA 2007 — Annual Conference The Drug Information Association’s 43rd annual meeting featured 450 sessions and more than 1,000 speakers. Industry Thought Leaders Raise their VOICE at DIA Podcasts BBK Worldwide...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
The ROI of ePRO
The ROI of ePRO Phil Lee, President and CEO The power of listening to the patient voice by using e-diary systems to collect the best PRO data possible and manage subject enrollment, compliance, and safety in real time may still be overlooked by some sponsors, who are hesitant to switch to eP...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
Pediatric Patient Retention: It's not Child's Play
Pediatric Patient Retention: It’s not Child’s Play Elizabeth Moench President and CEO Samantha Cook Pediatric Account Manager John Hartigan VP, Creative and Editorial Services The Ever-Changing Population A universal challenge of conducting long-term pediatric studies is the constant ...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
Benefits of Using an EDC System to Collect and Reconcile Serious Adverse Events
Benefits of Using an EDC System to Collect and Reconcile Serious Adverse Events Gary Tyson, Senior VP, Clinical Development Practice Marybeth Lynch, Associate Practice Executive, Clinical Development Practice Collecting and reconciling adverse events (AEs) and serious adverse events (SAEs)...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
Using Advanced Simulation in Clinical Operations
Using Advanced Simulation in Clinical Operations Jack Porter, President and CEO, ePharmamindshare The introduction of supercomputers and sophisticated simulation software for planning and optimizing clinical trials is rapidly becoming established in the pharmaceutical industry. These simulati...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
Overcoming Poor Quality Data for ECG Collection
Overcoming Poor Quality Data for ECG Collection Timothy Callahan, Ph.D., Chief Scientific Officer The ICH E14 has become the touchstone guideline when designing and implementing Thorough QT (TQT) trials. Even protocols that are not designed primarily as a QT trial often use recommendations fr...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
Integration and Workflow Issues for Clinical-Services Providers to Ensure Smooth Trials
Integration and Workflow Issues for Clinical-Services Providers to Ensure Smooth Trials Mary T. Stefanzick, Associate Director of Operations An ongoing imperative in clinical research for pharma and biotech companies is to accelerate processes and timelines to get new products to market ...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
Table of Contents
Letter from the Editor The Forum Clinical Services: Managing the Moving Parts — The clinical-research process is complex and requires integrated, sophisticated processes, technologies, and management to reduce costs, improve timelines, and produce safe therapeutics. Company Listing by Topic of In...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
Clinical Services: Managing the Moving Parts
Clinical Services: Managing the Moving Parts By Taren Grom, Editor The Cost of Doing Business The cost of drug development remains on the rise, with most estimates showing that the clinical-trials stage alone accounts for 40% of all costs related to R&D. Our Forum experts discuss...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
New Techniques Drive Patient Enrollment for Trials
New Techniques Drive Patient Enrollment for Trials The number of clinical trials for new drugs continues to grow, increasing the competition for patients. IMS data show that new drug-discovery technologies are fueling record worldwide growth. There are more than 13,000 studies projected for 20...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
Guidance and Technology: A Single-Source Solution
Guidance and Technology: A Single-Source Solution Rick Piazza, VP, Product Strategy In today’s technology-reliant clinical-trial studies, it is crucial that software providers maintain a staff of in-house experts to offer counsel and guidance to sponsors. These experts act as process partne...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
Inverting the Enrollment Trend of Clinical Trials
Inverting the Enrollment Trend of Clinical Trials One of the largest challenges facing the industry today is inverting the trend of clinical trials failing to complete enrollment on time. Raising awareness of a particular clinical trial with call-to-action advertising, such as broadcast televi...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
The Technologists
These innovators of technology-based solutions are improving connections across silos to facilitate the drug-development process and customer interactions. PharmaVOICE 100 July/August 2007 Vikas Vats The Sky’s the limit for innovation Current position VP, marketRx Place and date of Birth New Delh...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
The Researchers & Scientists
Matthew Coffey, Ph.D. Barry Eisenstein, M.D. Robert Lanza, M.D. Christine Smith Ana Szarfman, M.D., Ph.D. From discovery through clinical development, the researchers and scientists behind the medicines are making a significant impact on the pipelines of today and of the future. Current positions...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
The Patient Advocates
With an unwavering commitment to patients and protecting their rights, these forward-thinking individuals are advocating best practices for clinical-trial recruitment and education. Zane Wilson Speaking up for Those in Need Despite an often uphill battle to provide better facilities for patients ...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
Letter from the Editor
With so much negative press these days surrounding the pharmaceutical and life-sciences industries, it is our pleasure to once again be able to relate the positive aspects of our industry. We want to thank the thousands of individuals who took the time to send in their thoughtful write ups as par...
By Taren Grom • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
The Commanders & Chiefs
These champions of industry demonstrate their commitment to their employees, their companies, and their communities by setting high personal and corporate standards. Mehmood Khan, M.D. Mehmood Khan, M.D.’s favorite quote is from Michelangelo: Ancora Imparo, which translates into “I am still learn...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
What's New
New Healthcare-related Products, Services, and Companies TGaS Advisors Offers Collaborative Benchmarking Services for Pharmaceutical Companies Pharmastance operational resource lets companies learn where they stand. TGaS Advisors has launched the Pharmastance family of benchmarks. These collabora...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
Strategic Patient Adherence Awards
The SPA Awards cosponsored by CBI and PharmaVOICE were presented at the 6th Annual Forum on Patient Compliance, Adherence and Persistency. 6th annual Forum on patient compliance, adherence and persistency Informative presentations, executive thought leadership, and a prestigious awards ceremony p...
By PharmaVoice Team • Jan. 2, 2008
Previous
